191 related articles for article (PubMed ID: 7169635)
1. Three-dimensional structure of the complex between pancreatic secretory trypsin inhibitor (Kazal type) and trypsinogen at 1.8 A resolution. Structure solution, crystallographic refinement and preliminary structural interpretation.
Bolognesi M; Gatti G; Menagatti E; Guarneri M; Marquart M; Papamokos E; Huber R
J Mol Biol; 1982 Dec; 162(4):839-68. PubMed ID: 7169635
[No Abstract] [Full Text] [Related]
2. Preliminary crystallographic data for the structure of the complex between Kazal trypsin inhibitor and trypsinogen.
Bolognesi M; Coda A; Guarneri M; Menegatti E
J Mol Biol; 1981 Jan; 145(3):603-5. PubMed ID: 7265215
[No Abstract] [Full Text] [Related]
3. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
[TBL] [Abstract][Full Text] [Related]
4. Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type).
Hecht HJ; Szardenings M; Collins J; Schomburg D
J Mol Biol; 1992 Jun; 225(4):1095-103. PubMed ID: 1613792
[TBL] [Abstract][Full Text] [Related]
5. Trypsin activation. Effect of the Ile-Val dipeptide concentration on Kazal inhibitor binding to bovine trypsinogen.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
Biochim Biophys Acta; 1985 Dec; 832(3):378-82. PubMed ID: 4074755
[TBL] [Abstract][Full Text] [Related]
6. Binding of the bovine pancreatic secretory trypsin inhibitor (Kazal) to bovine serine (pro)enzymes.
Menegatti E; Guarneri M; Bolognesi M; Ascenzi P; Amiconi G
J Mol Biol; 1987 Nov; 198(1):129-32. PubMed ID: 3430603
[TBL] [Abstract][Full Text] [Related]
7. Structure of bovine trypsinogen at 1.9 A resolution.
Kossiakoff AA; Chambers JL; Kay LM; Stroud RM
Biochemistry; 1977 Feb; 16(4):654-64. PubMed ID: 556951
[TBL] [Abstract][Full Text] [Related]
8. The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. The refined crystal structures of the bovine trypsinogen-pancreatic trypsin inhibitor complex and of its ternary complex with Ile-Val at 1.9 A resolution.
Bode W; Schwager P; Huber R
J Mol Biol; 1978 Jan; 118(1):99-112. PubMed ID: 625059
[No Abstract] [Full Text] [Related]
9. Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases.
Papamokos E; Weber E; Bode W; Huber R; Empie MW; Kato I; Laskowski M
J Mol Biol; 1982 Jul; 158(3):515-37. PubMed ID: 6752426
[No Abstract] [Full Text] [Related]
10. Structure of the complex of Streptomyces griseus protease B and the third domain of the turkey ovomucoid inhibitor at 1.8-A resolution.
Read RJ; Fujinaga M; Sielecki AR; James MN
Biochemistry; 1983 Sep; 22(19):4420-33. PubMed ID: 6414511
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type).
Hecht HJ; Szardenings M; Collins J; Schomburg D
J Mol Biol; 1991 Aug; 220(3):711-22. PubMed ID: 1870127
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical distribution of trypsinogen and pancreatic secretory trypsin inhibitor in normal and neoplastic tissues in man.
Marks WH; Ohlsson K; Polling A
Scand J Gastroenterol; 1984 Jul; 19(5):673-6. PubMed ID: 6382569
[TBL] [Abstract][Full Text] [Related]
13. Computer simulation of the dynamics of hydrated protein crystals and its comparison with x-ray data.
van Gunsteren WF; Berendsen HJ; Hermans J; Hol WG; Postma JP
Proc Natl Acad Sci U S A; 1983 Jul; 80(14):4315-9. PubMed ID: 6576339
[TBL] [Abstract][Full Text] [Related]
14. Thermodynamic modeling of internal equilibria involved in the activation of trypsinogen.
Coletta M; Ascenzi P; Bravin L; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
J Biomol Struct Dyn; 1990 Feb; 7(4):959-72. PubMed ID: 2310525
[TBL] [Abstract][Full Text] [Related]
15. Binding of the Ile-Val and Val-Val effector dipeptides to the binary adducts of bovine trypsinogen with Kunitz and Kazal inhibitors as well as the acylating agent p-nitrophenyl p-guanidinobenzoate. A thermodynamic and kinetic study.
Ascenzi P; Amiconi G; Bolognesi M; Menegatti E; Guarneri M
J Mol Biol; 1987 Apr; 194(4):751-4. PubMed ID: 2443709
[TBL] [Abstract][Full Text] [Related]
16. Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution.
Huber R; Kukla D; Bode W; Schwager P; Bartels K; Deisenhofer J; Steigemann W
J Mol Biol; 1974 Oct; 89(1):73-101. PubMed ID: 4475115
[No Abstract] [Full Text] [Related]
17. Mechanisms of zymogen activation.
Stroud RM; Kossiakoff AA; Chambers JL
Annu Rev Biophys Bioeng; 1977; 6():177-93. PubMed ID: 17350
[No Abstract] [Full Text] [Related]
18. Interaction between serine (pro)enzymes, and Kazal and Kunitz inhibitors.
Antonini E; Ascenzi P; Bolognesi M; Gatti G; Guarneri M; Menegatti E
J Mol Biol; 1983 Apr; 165(3):543-58. PubMed ID: 6188849
[No Abstract] [Full Text] [Related]
19. [X-ray structure analyses of proteinase inhibitors].
Suzuki A; Yamane T; Ashida T
Tanpakushitsu Kakusan Koso; 1989 Jul; 34(8):929-38. PubMed ID: 2798908
[No Abstract] [Full Text] [Related]
20. Refined 2 A X-ray crystal structure of porcine pancreatic kallikrein A, a specific trypsin-like serine proteinase. Crystallization, structure determination, crystallographic refinement, structure and its comparison with bovine trypsin.
Bode W; Chen Z; Bartels K; Kutzbach C; Schmidt-Kastner G; Bartunik H
J Mol Biol; 1983 Feb; 164(2):237-82. PubMed ID: 6551452
[No Abstract] [Full Text] [Related]
[Next] [New Search]
